ArticleActa pharmacologica Sinica2021

Brexpiprazole caused glycolipid metabolic disorder by inhibiting GLP1/GLP1R signaling in rats.

De-Juan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.